About GenScript
GenScript is a company based in Piscataway (United States) founded in 2002. GenScript has raised $15 million across 1 funding round from investors including Kleiner Perkins. The company has 5,570 employees as of December 31, 2024. GenScript has completed 1 acquisition, including CustomArray. GenScript operates in a competitive market with competitors including Abcam, Sino Biological, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others.
- Headquarter Piscataway, United States
- Employees 5570 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genscript Biotech Corporation
-
Annual Revenue
$602.59 M (USD)6.9as on Dec 31, 2024
-
Net Profit
-$271.68 M (USD)-182.2as on Dec 31, 2024
-
EBITDA
$75.84 M (USD)-4.38as on Dec 31, 2024
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series A
Jun 23, 2009
- Investors
-
Employee Count
5570
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GenScript
GenScript is a publicly listed company on the HKEX with ticker symbol 1548 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of GenScript
Unlock access to complete
Unlock access to complete
Funding Insights of GenScript
GenScript has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GenScript
GenScript has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Kleiner Perkins.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for GenScript
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenScript
GenScript has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CustomArray.
Investment portfolio details for GenScript
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Array-synthesized DNA capture probes are developed for targeted NGS sequencing.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for GenScript
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - GenScript
Detailed financials for GenScript
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genscript Comparisons
Peer comparison for GenScript
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenScript
GenScript operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of GenScript
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genscript
Complete news archive for GenScript
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenScript
GenScript was founded in 2002 and raised its 1st funding round 7 years after it was founded.
GenScript is headquartered in Piscataway, United States. It is registered at Piscataway, New Jersey, United States.
Frank Zhang is the current CEO of GenScript.
GenScript is a funded company, having raised a total of $15M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at GenScript is 5,570.
Annual revenue of GenScript is $602.59M as on Dec 31, 2024.
GenScript was founded in 2002 and is headquartered in Piscataway, United States. Operations focus on the life sciences sector, where a range of services is offered, including bio-reagents, bio-assays, lead optimization, and antibody drug development. Emphasis is placed on CRISPR reagents for genome editing. Bioinformatics tools, such as those for molecular biology, peptides, and proteins, are also included in the portfolio.
GenScript's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Yes, GenScript is publicly traded on HKEX under the ticker symbol 1548.
GenScript has made 1 acquisition, including CustomArray.
GenScript has 1 investor. Key investors include Kleiner Perkins.
The ticker symbol of GenScript is 1548 on HKEX.